Ardent Health Partners (NYSE:ARDT) Price Target Lowered to $21.00 at Truist Financial

Ardent Health Partners (NYSE:ARDTFree Report) had its price objective cut by Truist Financial from $22.00 to $21.00 in a research note issued to investors on Monday morning,Benzinga reports. They currently have a buy rating on the stock.

Several other research firms also recently weighed in on ARDT. Royal Bank of Canada reiterated an “outperform” rating and set a $23.00 target price on shares of Ardent Health Partners in a research report on Thursday, November 14th. KeyCorp initiated coverage on shares of Ardent Health Partners in a report on Friday, October 11th. They set an “overweight” rating and a $24.00 price objective for the company. Stephens reissued an “overweight” rating and issued a $24.00 price objective on shares of Ardent Health Partners in a research report on Thursday, September 19th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $20.00 target price on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Finally, Bank of America lowered Ardent Health Partners from a “buy” rating to a “neutral” rating and lowered their price target for the company from $22.00 to $19.00 in a report on Wednesday, November 6th. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, Ardent Health Partners presently has an average rating of “Buy” and a consensus target price of $22.00.

View Our Latest Stock Report on Ardent Health Partners

Ardent Health Partners Price Performance

Shares of ARDT stock opened at $16.41 on Monday. The business’s 50 day simple moving average is $16.66. Ardent Health Partners has a 52-week low of $14.57 and a 52-week high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Institutional Investors Weigh In On Ardent Health Partners

A number of hedge funds and other institutional investors have recently bought and sold shares of ARDT. State Street Corp purchased a new position in shares of Ardent Health Partners in the 3rd quarter valued at approximately $1,977,000. Jane Street Group LLC acquired a new position in Ardent Health Partners during the 3rd quarter valued at approximately $567,000. Allspring Global Investments Holdings LLC purchased a new position in shares of Ardent Health Partners in the third quarter worth $13,119,000. Goldentree Asset Management LP acquired a new stake in shares of Ardent Health Partners during the third quarter worth $22,897,000. Finally, Franklin Resources Inc. acquired a new stake in shares of Ardent Health Partners during the third quarter worth $15,839,000.

Ardent Health Partners Company Profile

(Get Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Featured Articles

Analyst Recommendations for Ardent Health Partners (NYSE:ARDT)

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.